Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.15B | 3.41B | 3.03B | 3.12B | 3.98B | 6.79B |
Gross Profit | 1.28B | 1.39B | 1.24B | 1.21B | 1.41B | 1.56B |
EBITDA | -2.10B | 657.00M | -3.36B | -1.29B | 222.00M | 131.00M |
Net Income | -682.00M | 300.00M | -2.42B | -1.11B | -375.00M | 1.04B |
Balance Sheet | ||||||
Total Assets | 15.59B | 15.82B | 18.23B | 19.72B | 22.38B | 23.33B |
Cash, Cash Equivalents and Short-Term Investments | 834.00M | 937.00M | 739.00M | 1.54B | 3.10B | 2.97B |
Total Debt | 7.12B | 7.44B | 10.10B | 9.79B | 10.45B | 11.16B |
Total Liabilities | 13.55B | 13.90B | 16.61B | 17.16B | 18.58B | 19.14B |
Stockholders Equity | 2.05B | 1.92B | 1.61B | 2.56B | 3.80B | 4.19B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.45B | -1.92B | -1.53B | -1.41B | -1.94B |
Operating Cash Flow | 0.00 | -517.00M | -1.40B | -1.42B | -1.24B | -1.60B |
Investing Cash Flow | 0.00 | 3.39B | 287.00M | 466.00M | 2.07B | 4.54B |
Financing Cash Flow | 0.00 | -2.68B | 295.00M | -719.00M | -707.00M | -792.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥88.04B | 10.83 | 2.94% | 7.01% | 11.28% | ||
68 Neutral | ¥2.81B | 8.77 | 2.90% | 8.57% | 140.21% | ||
66 Neutral | ¥12.18B | 13.50 | 5.04% | 1.05% | 5.07% | ||
60 Neutral | ¥2.47B | 27.39 | 1.72% | -5.89% | -57.98% | ||
57 Neutral | HK$26.40B | 4.11 | -2.03% | 5.49% | -0.23% | -68.02% | |
50 Neutral | ¥1.92B | 6.40 | ― | 12.55% | ― |